Biodyne Co., Ltd. (KOSDAQ:314930)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,660.00
-340.00 (-3.40%)
At close: May 20, 2026
Market Cap287.52B -29.4%
Revenue (ttm)4.98B +9.0%
Net Income-78.64M
EPS-2.64
Shares Out29.76M
PE Ration/a
Forward PE65.16
Dividendn/a
Ex-Dividend Daten/a
Volume58,169
Average Volume58,092
Open9,840.00
Previous Close10,000.00
Day's Range9,580.00 - 10,350.00
52-Week Range9,580.00 - 18,420.00
Beta1.16
RSI22.26
Earnings DateMay 21, 2026

About Biodyne

Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314930
Full Company Profile

Financial Performance

Financial Statements